Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jerome Ritz(Dana-Farber Cancer Institute), Herbert Levine(Boston University), Dedra Buchwald(University of Washington), Paul R. Cheney, Anthony L. Komaroff(Brigham and Women's Hospital), Daniel L. Peterson, Christine Murray(Dana-Farber Cancer Institute)
Cited by 289
Related Papers
Chronic Fatigue Syndrome: A Review
|American Journal of Psychiatry|2003|690
Overlapping Conditions Among Patients With Chronic Fatigue Syndrome, Fibromyalgia, and Temporomandibular Disorder
|Archives of Internal Medicine|2000|602
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468
Evidence for discrete stages of human natural killer cell differentiation in vivo
|The Journal of Experimental Medicine|2006|429